CDC officials say medical professionals are seeing more patients whose illness cannot be traced back to an infected animal or ...

The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and ...

The main reason for this week's decline is that Moderna lowered its 2025 full-year revenue guidance, and by a wide margin.

President Joe Biden's outgoing administration on Thursday announced $211 million in new funding to develop mRNA vaccines ...

Dame Tracey Emin and Sir Grayson Perry are celebrated with solo exhibitions at the suitably palatial Palazzo Strozzi in ...

It was an extremely busy week in the biotech sector, with several companies making important presentations at the J.P. Morgan ...

Morgan Stanley slashed its price target on Moderna Inc (BMV:MRNA) (NASDAQ:MRNA) to $38 from $70 given the lowered revenue guidance and ongoing competitive pressures in the vaccine market.

Annemarie Hanekamp has overseen some of the most transformative changes in oncology over her years in Big Pharma. Now, she ...

Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market ...

Moderna (NASDAQ: MRNA) shareholders have been having a rough time lately. The biotech stock rocketed higher last spring, but ...